Astrana Health earnings were $35.0M for the trailing 12 months ending Mar 31, 2025, with -43.9% growth year over year. The latest ASTH earnings report on Mar 31, 2025 announced Q1 2025 earnings of $6.7M, down 196.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ASTH reported annual earnings of $43.1M, with -28.9% growth. The next ASTH earnings date is Jul 31, 2025.
ASTH past earnings growth
How has ASTH's earnings growth performed historically?
On ASTH's earnings call on Invalid Date, Astrana Health (NASDAQ: ASTH) reported Q1 2025 earnings per share (EPS) of $0.14, up 54.84% year over year. Total ASTH earnings for the quarter were $6.69 million. In the same quarter last year, Astrana Health's earnings per share (EPS) was $0.31.
The next ASTH earnings date is Invalid Date. Add ASTH to your watchlist to be reminded of Astrana Health's next earnings date.
Is Astrana Health profitable or losing money?
As of the last Astrana Health earnings report, Astrana Health is currently profitable. Astrana Health's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $35.01 million, a 43.92% decrease year over year.
What was ASTH's earnings growth in the past year?
As of Astrana Health's earnings date in Invalid Date, Astrana Health's earnings has grown -43.94% year over year. This is 56.65 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 12.71%. ASTH earnings in the past year totalled $35.01 million.
What are Astrana Health's earnings expectations?
The current EPS estimate for Astrana Health's earnings report in Invalid Date is $0.35.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.